PET-Technology Portfolio Company Opened Its First Nuclear Medicine Centre in Rostov-on-Don
On June 22, Rostov-on-Don saw the opening of the 11th centre of the national nuclear medicine network PET-Technology created with the participation of RUSNANO. Now the inhabitants of the Rostov Region and the neighbouring regions have one of the crucial oncology diagnostic methods available, namely the PET/CT scan. PET-Technology’s investment in the Centre exceeded RUB 200 mln, the company’s total investment in the national nuclear medicine network reached RUB 4.6 bln.
The PET Centre opening ceremony saw the participation of the Chairman of the Executive Board of RUSNANO MC LLC Anatoly Chubais, the Rostov Region Governor Vasily Golubev, the MedInvestGroup Managing Partner Sergey Notov and the PET-Technology CEO Diana Kobesova.
Doctors diagnose an average of 14,000 cancer cases in the Rostov Region annually, at least 4,500 of them need a PET/CT scan. The recently opened diagnostic centre will be able to perform 5,000 PET/CT scans annually and meet the region’s need for this cutting-edge diagnostic method. The Centre is equipped with a General Electric PET/CT scanner, whose capacity enables to scan up to 30 patients daily.
The diagnostic centre of PET-Technology is located in the territory of the Zdorovie (“Health”) Clinical and Diagnostic Centre. The inhabitants of the Rostov Region and the neighbouring regions will be able to have a scan in just 2–3 days after the oncologist orders it. The diagnosis of every patient is performed with radiopharmaceuticals manufactured by PET-Technology at its own factory in Yelets that has a Good Manufacturing Practices (GMP) Certificate. Radiopharmaceuticals will be delivered to Rostov-on-Don on a daily basis by special land and air transport.
The Chairman of the Executive Board of RUSNANO MC LLC Anatoly Chubais: “Cardiovascular and oncological diseases are the main death causes in the country. We have chosen the location for the new PET Centre in Rostov-on-Don to make the cutting-edge diagnostic technology available to the whole Russian South. Since the PET-Technology network was established, over 72,000 people have undergone oncology diagnosis in our centres. Due to the efficient visualisation of the focus of a disease, the PET/CT scan has become the gold standard of oncological diseases treatment.”
The PET-Technology CEO Diana Kobesova: “Highly accurate diagnosis plays the crucial part in combatting oncological diseases. Today, the state-of-the-art method became available for the Rostov citizens. The PET-Technology Centre working in accordance with international standards with cutting-edge equipment is called to meet the region’s need for this type of medical examination to a great extent and complement the work of the regional medical institutions combatting oncology.”
The Rostov Region Governor Vasily Golubev: “Opening the Nuclear Medicine Centre is another step towards increasing the availability of quality healthcare. The Don River region healthcare cluster received a new state-of-the-art technology that enables to diagnose oncological diseases at an early stage and control the treatment using innovative equipment. As a result, the local doctors will be more successful in combatting this lethal disease and saving more human lives.”
RUSNANO Joint-Stock Company was founded in March 2011 through reorganization of state corporation Russian Corporation of Nanotechnologies. JSC RUSNANO contributes to implementation of the state policy on the development of the nanotechnology industry by investing directly and through investment funds of nanotechnology in financially effective high-technology projects providing the development of new production facilities in the Russian Federation. Its primary investment focus is in electronics, optoelectronics and telecommunications, healthcare and biotechnology, metallurgy and metalwork, energy, mechanical engineering and instrument making, construction and industrial materials, chemicals and petrochemicals. 100 percent of RUSNANO’s shares are state owned. Thanks to RUSNANO’s investments, there are currently 97 factories and R&D Centers opened in 37 regions in Russia. JSC RUSNANO has profit for the last 4 years.
Management of assets of RUSNANO JSC is carried out by Limited Liability Company established in December 2013, RUSNANO Management Company. Anatoly Chubais is the Chairman of its Executive Board.
Work to establish nanotechnology infrastructure and carry out educational programs is fulfilled by RUSNANO’s Fund for Infrastructure and Educational Programs, which was also established during the reorganization of the Russian Corporation of Nanotechnologies.
* * *
PET-Technology LLC, RUSNANO’s Portfolio Company, was founded in 2011 in order to implement the project “Establishment of a network of regional PET/CT Centers for diagnostic procedures”—Nuclear Medicine Centers.
Currently, there are 10 diagnostic centres in operation in Moscow, Kursk, Belgorod, Yekaterinburg, Ufa, Lipetsk, Orel, Tambov, Togliatti and Samara, as well as 2
The company’s overall goal is to increase the availability of highly effective methods of diagnosis and treatment of cancer in Russia. In accordance with the territorial strategy for the development of nuclear medicine centres, PET-Technology plans to open 10 new diagnostic centres by 2020, and 25 by 2025.